CICCONE, LIDIA Statistiche
CICCONE, LIDIA
DIPARTIMENTO DI FARMACIA
A new crystal form of human transthyretin obtained with a curcumin derived ligand
2016-01-01 Polsinelli, Ivan; Nencetti, Susanna; Shepard, William; Ciccone, Lidia; Orlandini, Elisabetta; Stura, Enrico A.
A Soluble Metabolon Synthesizes the Isoprenoid Lipid Ubiquinone
2019-01-01 Hajj Chehade, M.; Pelosi, L.; Fyfe, C. D.; Loiseau, L.; Rascalou, B.; Brugiere, S.; Kazemzadeh, K.; Vo, C. -D. -T.; Ciccone, L.; Aussel, L.; Coute, Y.; Fontecave, M.; Barras, F.; Lombard, M.; Pierrel, F.
Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators
2021-01-01 Nocentini, A.; Cuffaro, D.; Ciccone, L.; Orlandini, E.; Nencetti, S.; Nuti, E.; Rossello, A.; Supuran, C. T.
Antioxidant quercetin 3-O-glycosylated plant flavonols contribute to Transthyretin stabilization
2022-01-01 Ciccone, L.; Tonali, N.; Fruchart-Gaillard, C.; Barlettani, L.; Rossello, A.; Braca, A.; Orlandini, E.; Nencetti, S.
Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs
2021-01-01 Tonali, Nicoló; Nencetti, Susanna; Orlandini, Elisabetta; Ciccone, Lidia
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization
2017-01-01 Nuti, Elisa; Rosalia, Lea; Cuffaro, Doretta; Camodeca, Caterina; Giacomelli, Chiara; DA POZZO, Eleonora; Tuccinardi, Tiziano; Costa, Barbara; Antoni, Claudia; Vera, Laura; Ciccone, Lidia; Orlandini, Elisabetta; Nencetti, Susanna; Dive, Vincent; Martini, Claudia; Stura, Enrico A.; Rossello, Armando
Carbonic anhydrase inhibitors and epilepsy: State of the art and future perspectives
2021-01-01 Ciccone, L.; Cerri, C.; Nencetti, S.; Orlandini, E.
Comparison of helical scan and standard rotation methods in single-crystal X-ray data collection strategies
2017-01-01 Polsinelli, Ivan; Savko, Martin; Rouanet Mehouas, Cecile; Ciccone, Lidia; Nencetti, Susanna; Orlandini, Elisabetta; Stura, Enrico A.; Shepard, William
Complete PCSK9 C-ter domain in complex with VHH P1.40
2021-01-01 Ciccone, L.; Legrand, P.; Stura, E. A.; Dive, V.; Seidahn, N. G.; Fruchart Gaillard, C.
Copper mediated amyloid-β binding to Transthyretin
2018-01-01 Ciccone, Lidia; Fruchart-Gaillard, Carole; Mourier, Gilles; Savko, Martin; Nencetti, Susanna; Orlandini, Elisabetta; Servent, Denis; Stura, Enrico A.; Shepard, William
Cryoprotection and ligand solubilization: Evaluation of multicomponent mixtures
2014-01-01 Ciccone, Lidia; Vera, L; Tepshi, L; Stura, Ea
Crystal structure of a dimeric based inhibitor JG34 in complex with the MMP-12 catalytic domain
2021-01-01 Ciccone, L.; Rossello, A.; Vera, L.; Nuti, E.; Stura, E. A.
Crystal structure of MMP12 in complex with inhibitor BE4
2018-01-01 Ciccone, L.; Tepshi, L.; Nuti, E.; Rossello, A.; Stura, E. A.
Crystal structure of MMP12 in complex with inhibitor BE7
2018-01-01 Ciccone, L.; Tepshi, L.; Nuti, E.; Rossello, A.; Stura, E. A.
Crystal structure of MMP9 in complex with inhibitor BE4
2018-01-01 Ciccone, L.; Tepshi, L.; Nuti, E.; Rossello, A.; Stura, E. A.
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated arylsulfonamide carboxylate water-soluble inhibitor (DC27)
2016-01-01 Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A.
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated thiourea-linked carboxylate zinc-chelator water-soluble inhibitor (DC31)
2016-01-01 Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A.
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelating water-soluble inhibitor (DC24)
2016-01-01 Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A.
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelator water-soluble inhibitor (DC32)
2016-01-01 Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A.
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate zinc-chelator water-soluble inhibitor (DC28)
2016-01-01 Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A new crystal form of human transthyretin obtained with a curcumin derived ligand | 1-gen-2016 | Polsinelli, Ivan; Nencetti, Susanna; Shepard, William; Ciccone, Lidia; Orlandini, Elisabetta; Stura, Enrico A. | |
A Soluble Metabolon Synthesizes the Isoprenoid Lipid Ubiquinone | 1-gen-2019 | Hajj Chehade, M.; Pelosi, L.; Fyfe, C. D.; Loiseau, L.; Rascalou, B.; Brugiere, S.; Kazemzadeh, K.; Vo, C. -D. -T.; Ciccone, L.; Aussel, L.; Coute, Y.; Fontecave, M.; Barras, F.; Lombard, M.; Pierrel, F. | |
Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators | 1-gen-2021 | Nocentini, A.; Cuffaro, D.; Ciccone, L.; Orlandini, E.; Nencetti, S.; Nuti, E.; Rossello, A.; Supuran, C. T. | |
Antioxidant quercetin 3-O-glycosylated plant flavonols contribute to Transthyretin stabilization | 1-gen-2022 | Ciccone, L.; Tonali, N.; Fruchart-Gaillard, C.; Barlettani, L.; Rossello, A.; Braca, A.; Orlandini, E.; Nencetti, S. | |
Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs | 1-gen-2021 | Tonali, Nicoló; Nencetti, Susanna; Orlandini, Elisabetta; Ciccone, Lidia | |
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization | 1-gen-2017 | Nuti, Elisa; Rosalia, Lea; Cuffaro, Doretta; Camodeca, Caterina; Giacomelli, Chiara; DA POZZO, Eleonora; Tuccinardi, Tiziano; Costa, Barbara; Antoni, Claudia; Vera, Laura; Ciccone, Lidia; Orlandini, Elisabetta; Nencetti, Susanna; Dive, Vincent; Martini, Claudia; Stura, Enrico A.; Rossello, Armando | |
Carbonic anhydrase inhibitors and epilepsy: State of the art and future perspectives | 1-gen-2021 | Ciccone, L.; Cerri, C.; Nencetti, S.; Orlandini, E. | |
Comparison of helical scan and standard rotation methods in single-crystal X-ray data collection strategies | 1-gen-2017 | Polsinelli, Ivan; Savko, Martin; Rouanet Mehouas, Cecile; Ciccone, Lidia; Nencetti, Susanna; Orlandini, Elisabetta; Stura, Enrico A.; Shepard, William | |
Complete PCSK9 C-ter domain in complex with VHH P1.40 | 1-gen-2021 | Ciccone, L.; Legrand, P.; Stura, E. A.; Dive, V.; Seidahn, N. G.; Fruchart Gaillard, C. | |
Copper mediated amyloid-β binding to Transthyretin | 1-gen-2018 | Ciccone, Lidia; Fruchart-Gaillard, Carole; Mourier, Gilles; Savko, Martin; Nencetti, Susanna; Orlandini, Elisabetta; Servent, Denis; Stura, Enrico A.; Shepard, William | |
Cryoprotection and ligand solubilization: Evaluation of multicomponent mixtures | 1-gen-2014 | Ciccone, Lidia; Vera, L; Tepshi, L; Stura, Ea | |
Crystal structure of a dimeric based inhibitor JG34 in complex with the MMP-12 catalytic domain | 1-gen-2021 | Ciccone, L.; Rossello, A.; Vera, L.; Nuti, E.; Stura, E. A. | |
Crystal structure of MMP12 in complex with inhibitor BE4 | 1-gen-2018 | Ciccone, L.; Tepshi, L.; Nuti, E.; Rossello, A.; Stura, E. A. | |
Crystal structure of MMP12 in complex with inhibitor BE7 | 1-gen-2018 | Ciccone, L.; Tepshi, L.; Nuti, E.; Rossello, A.; Stura, E. A. | |
Crystal structure of MMP9 in complex with inhibitor BE4 | 1-gen-2018 | Ciccone, L.; Tepshi, L.; Nuti, E.; Rossello, A.; Stura, E. A. | |
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated arylsulfonamide carboxylate water-soluble inhibitor (DC27) | 1-gen-2016 | Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A. | |
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated thiourea-linked carboxylate zinc-chelator water-soluble inhibitor (DC31) | 1-gen-2016 | Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A. | |
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelating water-soluble inhibitor (DC24) | 1-gen-2016 | Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A. | |
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelator water-soluble inhibitor (DC32) | 1-gen-2016 | Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A. | |
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate zinc-chelator water-soluble inhibitor (DC28) | 1-gen-2016 | Stura, E. A.; Rosalia, L.; Cuffaro, D.; Tepshi, L.; Ciccone, L.; Rossello, A. |